Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck announces Phase 3 trial initiations for 4 investigational candidates from its hematology, oncology pipeline

Ruchika Sharma6 Jan 2024 12:30 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of pivotal Phase 3 trials for four of its...

Import Nod on Hold Over False Positives, Tissue Detection: CDSCO Panel Seeks More Data on Medtronics PTeye Device

Medtronic gets CE Mark for next generation Micra leadless pacing systems

Ruchika Sharma6 Jan 2024 11:32 AM IST

Medtronic projects the battery life of Micra AV2 and Micra VR2 is nearly 16 and 17 years, respectively.

GSK, Pfizer resolve patent lawsuit over RSV vaccines

Botox rival Revance loses bid to dismiss Allergan trade secrets lawsuit

Ruchika Sharma5 Jan 2024 4:15 PM IST

United States: A federal judge on Wednesday said Botox maker AbbVie's Allergan unit can move ahead with its lawsuit accusing Revance...

Merck seeks GLP-1 drugs with benefits beyond weight loss, says CEO

Ruchika Sharma5 Jan 2024 3:36 PM IST

Rahway: Merck & Co is seeking GLP-1 treatments with benefits beyond weight loss, CEO Robert Davis said on Thursday at a conference.Newer...

Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, Europe

Dr Reddy's Labs acquires entire MenoLabs supplements portfolio

Ruchika Sharma5 Jan 2024 1:30 PM IST

Brands include MenoFit and MenoGlow probiotics, Happy Fiber and Well Rested dietary supplements, Athena's Shield menopause support supplement, and...

Revenue of 25 leading domestic pharma cos expected to grow 9-11 percent in current fiscal year: ICRA

Ruchika Sharma5 Jan 2024 12:30 PM IST

New Delhi: Revenue of 25 leading domestic pharmaceutical companies is expected to grow 9-11 per cent in the current fiscal year, as per Icra.The...

Lupin bags tentative USFDA nod for Dapagliflozin and Saxagliptin Tablets

Ruchika Sharma5 Jan 2024 11:11 AM IST

Dapagliflozin and Saxagliptin Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes...

Esperion, Daiichi Sankyo Europe announce USD 125 million amendment to their collaboration, including resolution of pending litigation

Ruchika Sharma4 Jan 2024 4:45 PM IST

Ann Arbor: Esperion Therapeutics, Inc. and Daiichi Sankyo Europe GmbH (DSE), the European headquarter organization of the Japanese pharmaceutical...

Natco Pharma net profit down 23.44 percent at Rs 517.9 crore in Q2

Natco Pharma concludes transition of DASH Pharma into Natco Pharma USA

Ruchika Sharma4 Jan 2024 3:42 PM IST

Parsippany: Natco Pharma Limited, a research and development (R&D)-focused pharmaceutical company based in India, has announced that DASH...

Bristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone Lymphoma

Bristol Myers Squibb Repotrectinib application to treat cancer validated by EMA

Ruchika Sharma4 Jan 2024 1:30 PM IST

Princeton: Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has validated its marketing authorization application...

Genmab, AbbVie Face Setback as Epcoritamab Misses Survival Goal in Lymphoma Study

CVS Health to remove AbbVie rheumatoid arthritis drug Humira from some drug reimbursement lists in April

Ruchika Sharma4 Jan 2024 12:30 PM IST

A CVS spokesperson said the company expects most of its customers to transition their coverage to biosimilars of Humira, known chemically as...

Pfizer Sells ViiV Stake for USD 1.9 Billion, Shionogi Emerges Bigger Partner

Pfizer gene therapy for bleeding disorder approved in Canada

Ruchika Sharma4 Jan 2024 11:51 AM IST

Canada: Pfizer said on Wednesday that Canada's health regulator approved its gene therapy for the treatment of a rare inherited bleeding...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok